StonvexLoading…
StonvexStonvexStonvexCore line items from PJT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $410.95M | $1.70B | $1.17B | $723.02M |
Operating Income | $80.39M | $342.92M | $220.01M | $129.06M |
Net Income | $60.50M | $180.12M | $126.75M | $86.92M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $1.56B | $1.84B | $1.72B | $1.51B |
Total Liabilities | $634.06M | $834.21M | $788.70M | $662.80M |
Cash & Equivalents | $308.78M | $538.86M | $400.45M | $214.62M |
Free Cash Flow OCF − CapEx | $55.99M | $480.44M | $341.88M | $100.99M |
Shares Outstanding | Not available | Not available | Not available | Not available |